Progress and Pitfalls in the Use of Immunotherapy for Patients With Triple Negative Breast Cancer
Last Updated: Thursday, November 3, 2022
This review examines the available evidence on the use of immunotherapeutic strategies in early and advanced TNBC, discusses the pitfalls and limitations often encountered in clinical research, and summarizes data on novel promising immunomodulatory approaches that have been explored in early-phase trials.
Advertisement
News & Literature Highlights